---
title: Check Turkish temperature sensitivity questionnaire
nct_id: NCT07710625
status: RECRUITING
sponsor: Acibadem University
study_type: OBSERVATIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07710625"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07710625"
last_fetched: "2026-07-17T14:02:33.000Z"
source: "Parkinson's Pathways (curated)"
---
# Check Turkish temperature sensitivity questionnaire

**Goal (in five words):** Check Turkish temperature sensitivity questionnaire

**Official Title:** Cross-Cultural Adaptation and Psychometric Evaluation of the Turkish Version of the Temperature Sensitivity Scale in Individuals With Parkinson's Disease

**Trial ID:** [NCT07710625](https://clinicaltrials.gov/study/NCT07710625)

## Key Facts

- **Status:** RECRUITING
- **Study Type:** OBSERVATIONAL
- **Sponsor:** Acibadem University
- **Target Enrollment:** 100 participants
- **Start Date:** 2026-05-25
- **Completion Date:** 2026-12-25
- **Conditions:** Parkinson Disease, Temperature Sensivity

## Summary For Families

The goal is to check whether the Turkish version of the Temperature Sensitivity Scale gives consistent and trustworthy results when used with people who have Parkinson's disease. To do that, researchers will have patients complete the Turkish questionnaire and will test whether the questions hold together, whether answers stay the same on repeat testing, and whether the scale measures sensitivity to temperature. They are looking for people aged 40 to 85 with early to mid-stage Parkinson's (Hoehn and Yahr stage 1 to 3), who can communicate and score 24 or higher on the Mini-Mental State Examination, and they will exclude people with major psychiatric illness, advanced dementia, uncontrolled chronic diseases like diabetes or high blood pressure, serious heart or lung disease, other conditions that would affect testing, or severe vision or hearing problems.

## What This Actually Involves

**Placebo** _(From the protocol)_: This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.

**Visits** _(Ask the coordinator)_: Ask the coordinator how many in-person visits the study involves, how long each one takes, and over what total period.

**Procedures** _(Ask the coordinator)_: Ask the coordinator what tests and procedures are involved, for example blood draws, scans, or questionnaires, and whether any are uncomfortable or invasive.

**Washout** _(Ask the coordinator)_: Ask the coordinator whether you would need to stop or pause any of your current medications before or during the study (a washout period), and for how long.

**Travel & reimbursement** _(Ask the coordinator)_: Ask the coordinator whether travel, parking, or your time is reimbursed or compensated, and what is covered.

_Fields marked “From the protocol” come from the trial's registry record or quoted protocol text. Fields marked “Ask the coordinator” are not reliably available and should be confirmed directly._

## Eligibility

- **Minimum age:** 40 Years
- **Maximum age:** 85 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Clinical diagnosis of Parkinson's disease Hoehn and Yahr stage 1-3 Age between 40 and 85 years Mini-Mental State Examination (MMSE) score ≥ 24 Sufficient cognitive function to communicate and complete assessments Patients attending the Movement Disorders Outpatient Clinic of the Neurology Department Willingness to participate and provide written informed consent

Exclusion Criteria:

* Presence of psychiatric disorders (e.g., major depression or psychotic disorders) Diagnosis of advanced dementia Presence of uncontrolled systemic chronic diseases (e.g., diabetes mellitus or hypertension) Presence of severe cardiovascular or respiratory conditions Presence of additional orthopedic or neurological conditions that may affect test performance Severe visual or hearing impairments that could interfere with assessments Inability to cooperate adequately with the physiotherapist during assessments
```

## Locations (1)

- Acibadem University, Istanbul, Turkey, Turkey (Türkiye) _(41.0138, 28.9497)_
  - Nuray ALACA, (CONTACT), 05324251290, nuray.alaca@acibadem.edu.tr

---

*Canonical: https://parkinsonspathways.com/trial/NCT07710625*  
*HTML version: https://parkinsonspathways.com/trial/NCT07710625*  
*Source data: https://clinicaltrials.gov/study/NCT07710625*